Strides to exit investment in Arrow for AUD 394 million
In a separate filing, the company said its step-down subsidiary Strides Pharma Inc has entered into an arrangement to acquire 100 per cent stake in US-based generics company Vensun Pharmaceuticals Inc.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Pharmaceuticals